Clinical trial
Comparison of Three Combination Chemotherapy Regimens in Treating Women With…
NCT00004237 · Royal Marsden NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00004237 |
|---|---|
| Title | Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer |
| Official title | A Randomized Phase II Trial of Navelbine/Epirubicin Versus Navelbine/Mitozantrone Versus Cyclophosphamide/Adriamycin as Preoperative Chemotherapy in Patients With > or = 3cm Diameter Early Breast Cancer |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cyclophosphamide, doxorubicin hydrochloride, epirubicin hydrochloride, mitoxantrone hydrochloride, vinorelbine tartrate, conventional surgery, radiation therapy |
| Start date | Oct 1, 1998 |
| Completion | Sep 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: